Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy

Seizure

Volumn 15, Issue 4, 2006, Pages 235-241

  Lagae, Lieven ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Anti epileptic drugs; Childhood epilepsy; Cognition; Development; IQ; Neuropsychology

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ATTENTION; BENIGN CHILDHOOD EPILEPSY; CHILD; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; HUMAN; IMAGERY; INFORMATION PROCESSING; INTELLIGENCE QUOTIENT; LEARNING; MEDICAL RESEARCH; METHODOLOGY; MONOTHERAPY; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRESCRIPTION; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; REVIEW; TREATMENT OUTCOME; VERBAL MEMORY; WORKING MEMORY;

ANTICONVULSANTS; CHILD; COGNITION; EPILEPSY; HUMANS; LEARNING; NEUROPSYCHOLOGICAL TESTS;

EID: 33646272417     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2006.02.013     Document Type: Review

References (62)

1. Boel M. Behavioural and neuropsychological problems in refractory paediatric epilepsies. Eur J Paediatr Neurol 8 (2005) 291-297
2. Ellenberg J.H., Hirtz D.G., and Nelson K.B. Do seizures in children cause intellectual deterioration?. N Engl J Med 314 (1986) 1085-1088
3. Bourgeois B. Determining the effects of antiepileptic drugs on cognitive function in paediatric patients with epilepsy. J Child Neurol 19 Suppl. 1 (2004) S15-S24
4. Bourgeois B., Prensky A.L., Palkes H.S., et al. Intelligence in epilepsy: a prospective study in children. Ann Neurol 14 (1983) 438-444
5. Vanderlinden L., and Lagae L.G. Clinical predictors for outcome in infants with epilepsy. Pediatr Neurol 31 (2004) 52-55
6. Tromp S.C., Weber J.W., et al. Relative influence of epileptic seizures and of epilepsy syndrome on cognitive function. J Child Neurol 18 (2003) 407-412
7. Zaroff C.M., Devinsky O., Miles D., and Barr W.B. Cognitive and behavioural correlates of tuberous sclerosis complex. J Child Neurol 19 (2004) 847-852
8. Helmstaedter C., Kurthen M., Lux S., Reuber M., and Elger C.E. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 54 (2003) 425-432
9. Farwell J.R., et al. Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence. N Engl J Med 322 (1990) 364-369
10. Camfield C.S., Chaplin S., Doyle A.B., Shapiro S.H., Cummings C., and Camfield P.R. Side effects of phenobarbital in toddlers; behavioural and cognitive aspects. J Pediatr 95 (1979) 361-365
11. Vermeulen J., and Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22 (1995) 65-95
12. Auclair L., Isabelle J., Olivier D., David L., and Eric S. Deficit of preparatory attention in children with frontal lobe epilepsy. Neuropsychologia 43 (2005) 1701-1712
13. Boylan L.S. Peri-Ictal behavioral and cognitive changes. Epilepsy Behav 3 (2002) 16-26
14. Aldenkamp A.P., Overweg J., Gutter T., Beun A.M., Diepman L., and Mulder O.G. Effect of epilepsy, seizures and epileptiform EEG discharges on cognitive function. Acta Neurol Scand 93 (1996) 253-259
15. Aarts J.H., Binnie C.D., Smit A.M., and Wilkins A.J. Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain 107 (1984) 293-308
16. Aldenkamp A.P., and Arends J. Effects of epileptiform EEG discharges on cognitive function: is the concept of 'transient cognitive impairment' still valid?. Epilepsy Behav 5 (2004) S25-S34
17. Tonnby B., Nilsson H.L., Aldenkamp A.P., Alpherts W.C., Blennow G., Elmqvist D., et al. Withdrawal of antiepileptic medication in children. Correlation of cognitive function and plasma concentration-the multicentre 'Holmfrid' study. Epilepsy Res 19 (1994) 141-152
18. Ortinski P., and Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5 Suppl. 1 (2004) S60-S65
19. Aldenkamp A.P., Alpherts W.C., Blennow G., Elmqvist D., Heijbel J., Nilsson H.L., et al. Withdrawal of antiepileptic medication in children-effects on cognitive function: the Multicenter Holmfrid Study. Neurology 43 (1993) 41-50
20. Stiers P., Swillen A., De Smedt B., Lagae L., Devriendt K., D'Agostino E., et al. Atypical neuropsychological profile in a boy with 22q11.2 deletion syndrome. Neuropsychol Dev Cogn C Child Neuropsychol 11 (2005) 87-108
21. Wouters H, Fonteyne A, Lagae L, Stiers P, Assessment of specific memory impairment in a multiple disabled boy with fragile-X syndrome and temporal lobe epilepsy. Dev Med Child Neurol, in press.
22. Sankar R., and Holmes G.L. Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol 19 Suppl. 1 (2004) S6-S14
23. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101 (2004) 9861-9866
24. Noeker M., Haverkamp-Krois A., and Haverkamp F. Development of mental health dysfunction in childhood epilepsy. Brain Dev 27 (2005) 5-16
25. Aldenkamp A.P., De Krom M., and Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 44 Suppl. 4 (2003) 21-29
26. Devinsky O. Cognitive and behavioural effects of antiepileptic drugs. Epilepsia 36 Suppl. 2 (1995) S46-S65
27. Brunbech L., and Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy. Drugs 62 (2002) 593-604
28. Riva, et al. Discontinuation of phenobarbital in children: effects on neurocognitive behavior. Pediatr Neurol 14 (1996) 36-40
29. Smith D.B., Mattson R.H., Cramer J.A., et al. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 28 (1987) S50-S58
30. Meador K.J., Loring D.W., Huh K., et al. Comparative cognitive effects of anticonvulsants. Neurology 23 (1990) 129-137
31. Vining E.P.G., Mellits E.D., Dorsen M.M., et al. Psychologic and behavioural effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 80 (1987) 165-174
32. Calandre E.P., Dominguez-Granados R., Gomez-Rubio M., and Molina-Font J.A. Cognitive effects of long-term treatment with Phenobarbital and valproic acid in school children. Acta Neurol Scand 81 (1990) 504-506
33. Chen Y.J., Chow J.C., and Lee I.C. Comparison of the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res 44 (2001) 65-70
34. Forsythe I., Butler R., Berg I., and McGuire R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 33 (1991) 524-534
35. Mandelbaum D.E., and Burack G.D. The effect of seizure type and medication on cognitive and behavioral functioning in children with idiopathic epilepsy. Dev Med Child Neurol 39 (1997) 731-735
36. Martin R., Kuzniecky R., Ho S., et al. Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adults. Neurology 52 (1999) 321-327
37. Aldenkamp A.P., Baker G., Mulder O.G., et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 41 (2000) 1167-1178
38. Tatum IV W.O., French J.A., et al. Postmarketing experience with topiramate and cognition. Epilepsia 42 (2001) 1134-1140
39. Thompson P.J., Baxendale S.A., Duncan J.S., and Sander J.W.A.S. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 69 (2000) 636-641
40. Lee S., Sziklas V., Andermann F., et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 44 (2003) 339-347
41. Shorvon S.D. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 37 Suppl. 2 (1996) 18-22
42. Moreland E.C., Griesemer D.A., and Holden K.R. Topiramate for intractable childhood epilepsy. Seizure 8 (1999) 38-40
43. Aldenkamp A.P., Arends J., Bootsma H.P., et al. Randomized, double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 43 (2002) 19-26
44. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive and behavioural effects of carbamazepine and lamotrigine. Neurology 8 (2001) 1177-1182
45. Smith D., Baker G., Davies G., et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34 (1993) 312-322
46. Banks G.K., and Beran R.G. Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol 28 (1991) 230-237
47. Placidi F., Marciani M.G., Diomedi M., et al. Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. Acta Neurol Scand 102 (2000) 81-86
48. Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure 4 (1995) 233-236
49. Leary P.M., and Allie S. A new drug suitable for children and young people with epilepsy and intellectual impairments. Dev Med Child Neurol 37 (1995) 371
50. Beran R.G., and Gibson R.J. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 39 (1998) 280-282
51. Ettinger A.B., Weisbrot D.M., Saracco J., et al. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 39 (1998) 874-877
52. Eriksson A.S., Knutsson E., and Nergardh A. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy. Epilepsia 42 (2001) 230-236
53. Aldenkamp A.P., and Baker G. A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav 2 (2001) 85-91
54. Curran H.V., and Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 44 (1993) 529-533
55. Sabers A., Moller A., Dam M., et al. Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurol Scand 92 (1995) 19-27
56. Äikiä M., Kälviänen R., Sivenius J., Halonen T., and Riekkinen R.J. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 11 (1992) 199-203
57. McKnee P.J., Blacklaw J., Forrest G., et al. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 37 (1994) 27-32
58. Serdaroglu G., Kurul S., Tutuncuoglu S., Dirik E., and Sarioglu B. Oxcarbazepine in the treatment of childhood epilepsy. Pediatr Neurol 28 (2003) 37-41
59. Cramer J.A., De Rue K., Devinsky O., et al. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 4 (2003) 124-132
60. Neyens L.G.J., Alpherts W.C.J., and Aldenkamp A.P. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 411-419
61. Kossoff E.H., Bergey G.K., Freeman J.M., and Vining E.P. Levetiracetam psychosis in children with epilepsy. Epilepsia 42 (2001) 1611-1613
62. Lagae L., Buyse G., and Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 14 (2005) 66-71